Arcus Biosciences, Inc. RCUS · SEC Filings

website

601

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes can...

Price18.95

Market Cap2.65 B

Float103.32 M

CountryUS

SectorHealthcare

ExchangeNYSE

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Oct 22, 2026

424B5

PENDING FIXED PRICE OFFERING | Bank: Jefferies, Leerink Partners, TD Cowen

Oct 21, 2026

424B5

FIXED PRICE OFFERING | Offering amount: $250,025,000 | Shares: 13,700,000 | Price: $18.250 | Bank: Leerink Partners; Goldman Sachs & Co. LLC; Cantor; Mizuho; Truist Securities

Oct 31, 2025

424B5

SHELF OFFERING | Bank: Leerink Partners, Goldman Sachs & Co. LLC

Oct 30, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

Feb 18, 2025

424B5

Form 424B5 - Prospectus [Rule 424(b)(5)]

May 29, 2020

Registrations

TYPE

HEADLINE

FILED AT

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

Other

TYPE

HEADLINE

FILED AT